NORGES BANK - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 242 filers reported holding CYTOKINETICS INC in Q1 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.

Quarter-by-quarter ownership
NORGES BANK ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q4 2022$38,459,292
-3.6%
839,356
+1.9%
0.01%
-18.2%
Q3 2022$39,898,381
+34.9%
823,496
+9.4%
0.01%
+37.5%
Q2 2022$29,574,919
+34.7%
752,734
+26.2%
0.01%
+60.0%
Q1 2022$21,952,711
+389.4%
596,379
+187.8%
0.01%
+400.0%
Q3 2020$4,486,000
-8.1%
207,2000.0%0.00%0.0%
Q2 2020$4,884,000
+400.4%
207,200
+158.0%
0.00%
Q4 2016$976,00080,3210.00%
Other shareholders
CYTOKINETICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
BVF INC/IL 5,721,888$41,198,0004.18%
Virtus ETF Advisers LLC 93,309$672,0000.58%
IRONWOOD INVESTMENT MANAGEMENT LLC 105,324$758,0000.55%
LANSDOWNE PARTNERS (UK) LLP 2,647,981$19,065,0000.20%
WASATCH ADVISORS LP 1,761,882$12,686,0000.16%
PINNACLE ASSOCIATES LTD 888,415$6,397,0000.12%
ESSEX INVESTMENT MANAGEMENT CO LLC 84,690$610,0000.08%
Birchview Capital, LP 10,000$72,0000.05%
Piermont Capital Management Inc. 16,530$119,0000.04%
Tekla Capital Management LLC 137,797$992,0000.04%
View complete list of CYTOKINETICS INC shareholders